{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:55:39Z","timestamp":1791644139866,"version":"4.3.4"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["643558"],"award-info":[{"award-number":["643558"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.582833","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:38:28Z","timestamp":1603154308000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-\u03b3"],"prefix":"10.3389","volume":"11","author":[{"given":"Andy C.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil R.","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickita","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward. B.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuf\u00e1ria","family":"Muss\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal M. W.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Ivanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajko","family":"Reljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A Functional Role for Antibodies in Tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1006250","DOI":"10.1371\/journal.ppat.1006250","article-title":"Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine","volume":"13","author":"Prados-Rosales","year":"2017","journal-title":"PLoS Pathog"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2008.09.001","article-title":"Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy","volume":"89","author":"Buccheri","year":"2009","journal-title":"Tubercul (Edinb)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2006.03012.x","article-title":"Intranasal IFNgamma extends passive IgA antibody protection of mice against Mycobacterium tuberculosis lung infection","volume":"143","author":"Reljic","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70658-2","article-title":"A case for passive immunoprophylaxis against tuberculosis","volume":"6","author":"Reljic","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003189","article-title":"A novel human IgA monoclonal antibody protects against tuberculosis","volume":"186","author":"Balu","year":"2011","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.femsim.2004.01.004","article-title":"Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge","volume":"41","author":"Chambers","year":"2004","journal-title":"FEMS Immunol Med Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02593.x","article-title":"A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab\u2019) fragment prolong survival of mice infected with Mycobacterium tuberculosis","volume":"138","author":"Hamasur","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.257-263.2000","article-title":"Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro","volume":"68","author":"Eze","year":"2000","journal-title":"Infect Immun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2004.01.015","article-title":"Mouse monoclonal IgA binds to the galectin-3\/Mac-2 lectin from mouse macrophage cell lines","volume":"93","author":"Reljic","year":"2004","journal-title":"Immunol Lett"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01048","article-title":"Vaccines Against Antimicrobial Resistance","volume":"11","author":"Rosini","year":"2020","journal-title":"Front Immunol"},{"key":"B20","article-title":"Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcgammaRI (CD64) and fcalphaRI (CD89)","volume":"61","author":"van Egmond","year":"2001","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.4161\/mabs.2.6.13603","article-title":"Metrics for antibody therapeutics development","volume":"2","author":"Reichert","year":"2010","journal-title":"MAbs"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0905-1073","article-title":"Monoclonal antibody successes in the clinic","volume":"23","author":"Reichert","year":"2005","journal-title":"Nat Biotechnol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2015.999039","article-title":"Nebulization as a delivery method for mAbs in respiratory diseases","volume":"12","author":"Respaud","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-2478(99)00034-6","article-title":"The human Fc receptor for IgA (Fc alpha RI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis","volume":"68","author":"van Egmond","year":"1999","journal-title":"Immunol Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2003.01220.x","article-title":"Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR gamma chain on myeloid cells in blood and tissue","volume":"57","author":"Hamre","year":"2003","journal-title":"Scand J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.142.1.1","article-title":"Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival","volume":"142","author":"Armstrong","year":"1975","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013827107","article-title":"Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting","volume":"107","author":"Joller","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1126\/science.291.5508.1544","article-title":"Induction of direct antimicrobial activity through mammalian toll-like receptors","volume":"291","author":"Thoma-Uszynski","year":"2001","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5329.1091","article-title":"A macrophage invasion mechanism of pathogenic mycobacteria","volume":"277","author":"Schorey","year":"1997","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1084\/jem.191.2.287","article-title":"Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages","volume":"191","author":"Malik","year":"2000","journal-title":"J Exp Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.16.9578","article-title":"The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages","volume":"95","author":"Yuan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JB.180.4.801-808.1998","article-title":"Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog","volume":"180","author":"Cunningham","year":"1998","journal-title":"J Bacteriol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.smim.2014.10.005","article-title":"The role of B cells and humoral immunity in Mycobacterium tuberculosis infection","volume":"26","author":"Chan","year":"2014","journal-title":"Semin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2016.08.001","article-title":"Antibodies and tuberculosis","volume":"101","author":"Jacobs","year":"2016","journal-title":"Tubercul (Edinb)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2006.01.011","article-title":"Mucosal immunotherapy of tuberculosis: is there a value in passive IgA","volume":"86","author":"Reljic","year":"2006","journal-title":"Tubercul (Edinb)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.4110\/in.2019.19.e24","article-title":"Emerging Themes for the Role of Antibodies in Tuberculosis","volume":"19","author":"Tran","year":"2019","journal-title":"Immune Netw"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)12273-X","article-title":"Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol","volume":"349","author":"Condos","year":"1997","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2004.19.2.167","article-title":"Six-month therapy with aerosolized interferon-gamma for refractory multidrug-resistant pulmonary tuberculosis","volume":"19","author":"Koh","year":"2004","journal-title":"J Korean Med Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int J Pharm"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jps.20727","article-title":"Antibody structure, instability, and formulation","volume":"96","author":"Wang","year":"2007","journal-title":"J Pharm Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.1.182","article-title":"Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis","volume":"166","author":"Bothamley","year":"1992","journal-title":"J Infect Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0181714","DOI":"10.1371\/journal.pone.0181714","article-title":"Detection of anti-HspX antibodies and HspX protein in patient sera for the identification of recent latent infection by Mycobacterium tuberculosis","volume":"12","author":"Castro-Garza","year":"2017","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1998.00420.x","article-title":"Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis","volume":"48","author":"Wilkinson","year":"1998","journal-title":"Scand J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.582833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:38:31Z","timestamp":1603154311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.582833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2020.582833"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.582833","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"article-number":"582833"}}